Global Pediatric Orphan Drug Supply, Demand and Key Producers, 2024-2030

Description

Orphan drug development is crucial for children, who are disproportionately affected by rare diseases.

The global Pediatric Orphan Drug market size is expected to reach $ 151980 million by 2030, rising at a market growth of 11.3% CAGR during the forecast period (2024-2030).

This report studies the global Pediatric Orphan Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pediatric Orphan Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Orphan Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pediatric Orphan Drug total production and demand, 2019-2030, (Tons)
Global Pediatric Orphan Drug total production value, 2019-2030, (USD Million)
Global Pediatric Orphan Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons), (based on production site)
Global Pediatric Orphan Drug consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Pediatric Orphan Drug domestic production, consumption, key domestic manufacturers and share
Global Pediatric Orphan Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Pediatric Orphan Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Pediatric Orphan Drug production by Application, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
This report profiles key players in the global Pediatric Orphan Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Orphan Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Pediatric Orphan Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pediatric Orphan Drug Market, Segmentation by Type:
    Oncology
    Pulmonary
    Neurology
    Hematology
    Endocrinology
    Cardio-vascular
    Metabolic Disorders
    Others

Global Pediatric Orphan Drug Market, Segmentation by Application:
    0-1 Years
    1-3 Years
    3-6 Years
    6-12 Years
    ＞ 12 Years

Companies Profiled:
    Bristol-Myers Squibb
    Roche
    Novartis
    Johnson & Johnson
    Pfizer
    Amgen
    Sanofi
    AstraZeneca
    Takeda
    Vertex Pharmaceuticals
    AbbVie
    Biogen
    Eli Lilly

Key Questions Answered:
1. How big is the global Pediatric Orphan Drug market?
2. What is the demand of the global Pediatric Orphan Drug market?
3. What is the year over year growth of the global Pediatric Orphan Drug market?
4. What is the production and production value of the global Pediatric Orphan Drug market?
5. Who are the key producers in the global Pediatric Orphan Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Pediatric Orphan Drug Introduction
    1.2 World Pediatric Orphan Drug Supply & Forecast
        1.2.1 World Pediatric Orphan Drug Production Value (2019 & 2023 & 2030)
        1.2.2 World Pediatric Orphan Drug Production (2019-2030)
        1.2.3 World Pediatric Orphan Drug Pricing Trends (2019-2030)
    1.3 World Pediatric Orphan Drug Production by Region (Based on Production Site)
        1.3.1 World Pediatric Orphan Drug Production Value by Region (2019-2030)
        1.3.2 World Pediatric Orphan Drug Production by Region (2019-2030)
        1.3.3 World Pediatric Orphan Drug Average Price by Region (2019-2030)
        1.3.4 North America Pediatric Orphan Drug Production (2019-2030)
        1.3.5 Europe Pediatric Orphan Drug Production (2019-2030)
        1.3.6 China Pediatric Orphan Drug Production (2019-2030)
        1.3.7 Japan Pediatric Orphan Drug Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pediatric Orphan Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pediatric Orphan Drug Major Market Trends

2 Demand Summary
    2.1 World Pediatric Orphan Drug Demand (2019-2030)
    2.2 World Pediatric Orphan Drug Consumption by Region
        2.2.1 World Pediatric Orphan Drug Consumption by Region (2019-2024)
        2.2.2 World Pediatric Orphan Drug Consumption Forecast by Region (2025-2030)
    2.3 United States Pediatric Orphan Drug Consumption (2019-2030)
    2.4 China Pediatric Orphan Drug Consumption (2019-2030)
    2.5 Europe Pediatric Orphan Drug Consumption (2019-2030)
    2.6 Japan Pediatric Orphan Drug Consumption (2019-2030)
    2.7 South Korea Pediatric Orphan Drug Consumption (2019-2030)
    2.8 ASEAN Pediatric Orphan Drug Consumption (2019-2030)
    2.9 India Pediatric Orphan Drug Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Pediatric Orphan Drug Production Value by Manufacturer (2019-2024)
    3.2 World Pediatric Orphan Drug Production by Manufacturer (2019-2024)
    3.3 World Pediatric Orphan Drug Average Price by Manufacturer (2019-2024)
    3.4 Pediatric Orphan Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Pediatric Orphan Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Pediatric Orphan Drug in 2023
        3.5.3 Global Concentration Ratios (CR8) for Pediatric Orphan Drug in 2023
    3.6 Pediatric Orphan Drug Market: Overall Company Footprint Analysis
        3.6.1 Pediatric Orphan Drug Market: Region Footprint
        3.6.2 Pediatric Orphan Drug Market: Company Product Type Footprint
        3.6.3 Pediatric Orphan Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Pediatric Orphan Drug Production Value Comparison
        4.1.1 United States VS China: Pediatric Orphan Drug Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Pediatric Orphan Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Pediatric Orphan Drug Production Comparison
        4.2.1 United States VS China: Pediatric Orphan Drug Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Pediatric Orphan Drug Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Pediatric Orphan Drug Consumption Comparison
        4.3.1 United States VS China: Pediatric Orphan Drug Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Pediatric Orphan Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Pediatric Orphan Drug Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Pediatric Orphan Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Pediatric Orphan Drug Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Pediatric Orphan Drug Production (2019-2024)
    4.5 China Based Pediatric Orphan Drug Manufacturers and Market Share
        4.5.1 China Based Pediatric Orphan Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Pediatric Orphan Drug Production Value (2019-2024)
        4.5.3 China Based Manufacturers Pediatric Orphan Drug Production (2019-2024)
    4.6 Rest of World Based Pediatric Orphan Drug Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Pediatric Orphan Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Pediatric Orphan Drug Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Pediatric Orphan Drug Production (2019-2024)

5 Market Analysis by Type
    5.1 World Pediatric Orphan Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oncology
        5.2.2 Pulmonary
        5.2.3 Neurology
        5.2.4 Hematology
        5.2.5 Endocrinology
        5.2.6 Cardio-vascular
        5.2.7 Metabolic Disorders
        5.2.8 Others
    5.3 Market Segment by Type
        5.3.1 World Pediatric Orphan Drug Production by Type (2019-2030)
        5.3.2 World Pediatric Orphan Drug Production Value by Type (2019-2030)
        5.3.3 World Pediatric Orphan Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Pediatric Orphan Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 0-1 Years
        6.2.2 1-3 Years
        6.2.3 3-6 Years
        6.2.4 6-12 Years
        6.2.5 ＞ 12 Years
    6.3 Market Segment by Application
        6.3.1 World Pediatric Orphan Drug Production by Application (2019-2030)
        6.3.2 World Pediatric Orphan Drug Production Value by Application (2019-2030)
        6.3.3 World Pediatric Orphan Drug Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Details
        7.1.2 Bristol-Myers Squibb Major Business
        7.1.3 Bristol-Myers Squibb Pediatric Orphan Drug Product and Services
        7.1.4 Bristol-Myers Squibb Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Bristol-Myers Squibb Recent Developments/Updates
        7.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.2 Roche
        7.2.1 Roche Details
        7.2.2 Roche Major Business
        7.2.3 Roche Pediatric Orphan Drug Product and Services
        7.2.4 Roche Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Roche Recent Developments/Updates
        7.2.6 Roche Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Pediatric Orphan Drug Product and Services
        7.3.4 Novartis Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Details
        7.4.2 Johnson & Johnson Major Business
        7.4.3 Johnson & Johnson Pediatric Orphan Drug Product and Services
        7.4.4 Johnson & Johnson Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Johnson & Johnson Recent Developments/Updates
        7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Pediatric Orphan Drug Product and Services
        7.5.4 Pfizer Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Amgen
        7.6.1 Amgen Details
        7.6.2 Amgen Major Business
        7.6.3 Amgen Pediatric Orphan Drug Product and Services
        7.6.4 Amgen Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Amgen Recent Developments/Updates
        7.6.6 Amgen Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Pediatric Orphan Drug Product and Services
        7.7.4 Sanofi Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 AstraZeneca
        7.8.1 AstraZeneca Details
        7.8.2 AstraZeneca Major Business
        7.8.3 AstraZeneca Pediatric Orphan Drug Product and Services
        7.8.4 AstraZeneca Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 AstraZeneca Recent Developments/Updates
        7.8.6 AstraZeneca Competitive Strengths & Weaknesses
    7.9 Takeda
        7.9.1 Takeda Details
        7.9.2 Takeda Major Business
        7.9.3 Takeda Pediatric Orphan Drug Product and Services
        7.9.4 Takeda Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Takeda Recent Developments/Updates
        7.9.6 Takeda Competitive Strengths & Weaknesses
    7.10 Vertex Pharmaceuticals
        7.10.1 Vertex Pharmaceuticals Details
        7.10.2 Vertex Pharmaceuticals Major Business
        7.10.3 Vertex Pharmaceuticals Pediatric Orphan Drug Product and Services
        7.10.4 Vertex Pharmaceuticals Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Vertex Pharmaceuticals Recent Developments/Updates
        7.10.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 AbbVie
        7.11.1 AbbVie Details
        7.11.2 AbbVie Major Business
        7.11.3 AbbVie Pediatric Orphan Drug Product and Services
        7.11.4 AbbVie Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 AbbVie Recent Developments/Updates
        7.11.6 AbbVie Competitive Strengths & Weaknesses
    7.12 Biogen
        7.12.1 Biogen Details
        7.12.2 Biogen Major Business
        7.12.3 Biogen Pediatric Orphan Drug Product and Services
        7.12.4 Biogen Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Biogen Recent Developments/Updates
        7.12.6 Biogen Competitive Strengths & Weaknesses
    7.13 Eli Lilly
        7.13.1 Eli Lilly Details
        7.13.2 Eli Lilly Major Business
        7.13.3 Eli Lilly Pediatric Orphan Drug Product and Services
        7.13.4 Eli Lilly Pediatric Orphan Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Eli Lilly Recent Developments/Updates
        7.13.6 Eli Lilly Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pediatric Orphan Drug Industry Chain
    8.2 Pediatric Orphan Drug Upstream Analysis
        8.2.1 Pediatric Orphan Drug Core Raw Materials
        8.2.2 Main Manufacturers of Pediatric Orphan Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Pediatric Orphan Drug Production Mode
    8.6 Pediatric Orphan Drug Procurement Model
    8.7 Pediatric Orphan Drug Industry Sales Model and Sales Channels
        8.7.1 Pediatric Orphan Drug Sales Model
        8.7.2 Pediatric Orphan Drug Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Pediatric Orphan Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Pediatric Orphan Drug Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Pediatric Orphan Drug Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Pediatric Orphan Drug Production Value Market Share by Region (2019-2024)
 Table 5. World Pediatric Orphan Drug Production Value Market Share by Region (2025-2030)
 Table 6. World Pediatric Orphan Drug Production by Region (2019-2024) & (Tons)
 Table 7. World Pediatric Orphan Drug Production by Region (2025-2030) & (Tons)
 Table 8. World Pediatric Orphan Drug Production Market Share by Region (2019-2024)
 Table 9. World Pediatric Orphan Drug Production Market Share by Region (2025-2030)
 Table 10. World Pediatric Orphan Drug Average Price by Region (2019-2024) & (US$/kg)
 Table 11. World Pediatric Orphan Drug Average Price by Region (2025-2030) & (US$/kg)
 Table 12. Pediatric Orphan Drug Major Market Trends
 Table 13. World Pediatric Orphan Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
 Table 14. World Pediatric Orphan Drug Consumption by Region (2019-2024) & (Tons)
 Table 15. World Pediatric Orphan Drug Consumption Forecast by Region (2025-2030) & (Tons)
 Table 16. World Pediatric Orphan Drug Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Pediatric Orphan Drug Producers in 2023
 Table 18. World Pediatric Orphan Drug Production by Manufacturer (2019-2024) & (Tons)
 Table 19. Production Market Share of Key Pediatric Orphan Drug Producers in 2023
 Table 20. World Pediatric Orphan Drug Average Price by Manufacturer (2019-2024) & (US$/kg)
 Table 21. Global Pediatric Orphan Drug Company Evaluation Quadrant
 Table 22. World Pediatric Orphan Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Pediatric Orphan Drug Production Site of Key Manufacturer
 Table 24. Pediatric Orphan Drug Market: Company Product Type Footprint
 Table 25. Pediatric Orphan Drug Market: Company Product Application Footprint
 Table 26. Pediatric Orphan Drug Competitive Factors
 Table 27. Pediatric Orphan Drug New Entrant and Capacity Expansion Plans
 Table 28. Pediatric Orphan Drug Mergers & Acquisitions Activity
 Table 29. United States VS China Pediatric Orphan Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Pediatric Orphan Drug Production Comparison, (2019 & 2023 & 2030) & (Tons)
 Table 31. United States VS China Pediatric Orphan Drug Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
 Table 32. United States Based Pediatric Orphan Drug Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Pediatric Orphan Drug Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Pediatric Orphan Drug Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Pediatric Orphan Drug Production (2019-2024) & (Tons)
 Table 36. United States Based Manufacturers Pediatric Orphan Drug Production Market Share (2019-2024)
 Table 37. China Based Pediatric Orphan Drug Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Pediatric Orphan Drug Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Pediatric Orphan Drug Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Pediatric Orphan Drug Production, (2019-2024) & (Tons)
 Table 41. China Based Manufacturers Pediatric Orphan Drug Production Market Share (2019-2024)
 Table 42. Rest of World Based Pediatric Orphan Drug Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Pediatric Orphan Drug Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Pediatric Orphan Drug Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Pediatric Orphan Drug Production, (2019-2024) & (Tons)
 Table 46. Rest of World Based Manufacturers Pediatric Orphan Drug Production Market Share (2019-2024)
 Table 47. World Pediatric Orphan Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Pediatric Orphan Drug Production by Type (2019-2024) & (Tons)
 Table 49. World Pediatric Orphan Drug Production by Type (2025-2030) & (Tons)
 Table 50. World Pediatric Orphan Drug Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Pediatric Orphan Drug Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Pediatric Orphan Drug Average Price by Type (2019-2024) & (US$/kg)
 Table 53. World Pediatric Orphan Drug Average Price by Type (2025-2030) & (US$/kg)
 Table 54. World Pediatric Orphan Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Pediatric Orphan Drug Production by Application (2019-2024) & (Tons)
 Table 56. World Pediatric Orphan Drug Production by Application (2025-2030) & (Tons)
 Table 57. World Pediatric Orphan Drug Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Pediatric Orphan Drug Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Pediatric Orphan Drug Average Price by Application (2019-2024) & (US$/kg)
 Table 60. World Pediatric Orphan Drug Average Price by Application (2025-2030) & (US$/kg)
 Table 61. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 62. Bristol-Myers Squibb Major Business
 Table 63. Bristol-Myers Squibb Pediatric Orphan Drug Product and Services
 Table 64. Bristol-Myers Squibb Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Bristol-Myers Squibb Recent Developments/Updates
 Table 66. Bristol-Myers Squibb Competitive Strengths & Weaknesses
 Table 67. Roche Basic Information, Manufacturing Base and Competitors
 Table 68. Roche Major Business
 Table 69. Roche Pediatric Orphan Drug Product and Services
 Table 70. Roche Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Roche Recent Developments/Updates
 Table 72. Roche Competitive Strengths & Weaknesses
 Table 73. Novartis Basic Information, Manufacturing Base and Competitors
 Table 74. Novartis Major Business
 Table 75. Novartis Pediatric Orphan Drug Product and Services
 Table 76. Novartis Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Novartis Recent Developments/Updates
 Table 78. Novartis Competitive Strengths & Weaknesses
 Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
 Table 80. Johnson & Johnson Major Business
 Table 81. Johnson & Johnson Pediatric Orphan Drug Product and Services
 Table 82. Johnson & Johnson Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Johnson & Johnson Recent Developments/Updates
 Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
 Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 86. Pfizer Major Business
 Table 87. Pfizer Pediatric Orphan Drug Product and Services
 Table 88. Pfizer Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Pfizer Competitive Strengths & Weaknesses
 Table 91. Amgen Basic Information, Manufacturing Base and Competitors
 Table 92. Amgen Major Business
 Table 93. Amgen Pediatric Orphan Drug Product and Services
 Table 94. Amgen Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Amgen Recent Developments/Updates
 Table 96. Amgen Competitive Strengths & Weaknesses
 Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 98. Sanofi Major Business
 Table 99. Sanofi Pediatric Orphan Drug Product and Services
 Table 100. Sanofi Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Sanofi Recent Developments/Updates
 Table 102. Sanofi Competitive Strengths & Weaknesses
 Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 104. AstraZeneca Major Business
 Table 105. AstraZeneca Pediatric Orphan Drug Product and Services
 Table 106. AstraZeneca Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. AstraZeneca Recent Developments/Updates
 Table 108. AstraZeneca Competitive Strengths & Weaknesses
 Table 109. Takeda Basic Information, Manufacturing Base and Competitors
 Table 110. Takeda Major Business
 Table 111. Takeda Pediatric Orphan Drug Product and Services
 Table 112. Takeda Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Takeda Recent Developments/Updates
 Table 114. Takeda Competitive Strengths & Weaknesses
 Table 115. Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 116. Vertex Pharmaceuticals Major Business
 Table 117. Vertex Pharmaceuticals Pediatric Orphan Drug Product and Services
 Table 118. Vertex Pharmaceuticals Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Vertex Pharmaceuticals Recent Developments/Updates
 Table 120. Vertex Pharmaceuticals Competitive Strengths & Weaknesses
 Table 121. AbbVie Basic Information, Manufacturing Base and Competitors
 Table 122. AbbVie Major Business
 Table 123. AbbVie Pediatric Orphan Drug Product and Services
 Table 124. AbbVie Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. AbbVie Recent Developments/Updates
 Table 126. AbbVie Competitive Strengths & Weaknesses
 Table 127. Biogen Basic Information, Manufacturing Base and Competitors
 Table 128. Biogen Major Business
 Table 129. Biogen Pediatric Orphan Drug Product and Services
 Table 130. Biogen Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Biogen Recent Developments/Updates
 Table 132. Biogen Competitive Strengths & Weaknesses
 Table 133. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 134. Eli Lilly Major Business
 Table 135. Eli Lilly Pediatric Orphan Drug Product and Services
 Table 136. Eli Lilly Pediatric Orphan Drug Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Eli Lilly Recent Developments/Updates
 Table 138. Eli Lilly Competitive Strengths & Weaknesses
 Table 139. Global Key Players of Pediatric Orphan Drug Upstream (Raw Materials)
 Table 140. Global Pediatric Orphan Drug Typical Customers
 Table 141. Pediatric Orphan Drug Typical Distributors


List of Figures
 Figure 1. Pediatric Orphan Drug Picture
 Figure 2. World Pediatric Orphan Drug Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Pediatric Orphan Drug Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Pediatric Orphan Drug Production (2019-2030) & (Tons)
 Figure 5. World Pediatric Orphan Drug Average Price (2019-2030) & (US$/kg)
 Figure 6. World Pediatric Orphan Drug Production Value Market Share by Region (2019-2030)
 Figure 7. World Pediatric Orphan Drug Production Market Share by Region (2019-2030)
 Figure 8. North America Pediatric Orphan Drug Production (2019-2030) & (Tons)
 Figure 9. Europe Pediatric Orphan Drug Production (2019-2030) & (Tons)
 Figure 10. China Pediatric Orphan Drug Production (2019-2030) & (Tons)
 Figure 11. Japan Pediatric Orphan Drug Production (2019-2030) & (Tons)
 Figure 12. Pediatric Orphan Drug Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 15. World Pediatric Orphan Drug Consumption Market Share by Region (2019-2030)
 Figure 16. United States Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 17. China Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 18. Europe Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 19. Japan Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 20. South Korea Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 21. ASEAN Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 22. India Pediatric Orphan Drug Consumption (2019-2030) & (Tons)
 Figure 23. Producer Shipments of Pediatric Orphan Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Pediatric Orphan Drug Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Pediatric Orphan Drug Markets in 2023
 Figure 26. United States VS China: Pediatric Orphan Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Pediatric Orphan Drug Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Pediatric Orphan Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Pediatric Orphan Drug Production Market Share 2023
 Figure 30. China Based Manufacturers Pediatric Orphan Drug Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Pediatric Orphan Drug Production Market Share 2023
 Figure 32. World Pediatric Orphan Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Pediatric Orphan Drug Production Value Market Share by Type in 2023
 Figure 34. Oncology
 Figure 35. Pulmonary
 Figure 36. Neurology
 Figure 37. Hematology
 Figure 38. Endocrinology
 Figure 39. Cardio-vascular
 Figure 40. Metabolic Disorders
 Figure 41. Others
 Figure 42. Metabolic Disorders
 Figure 43. World Pediatric Orphan Drug Production Market Share by Type (2019-2030)
 Figure 44. World Pediatric Orphan Drug Production Value Market Share by Type (2019-2030)
 Figure 45. World Pediatric Orphan Drug Average Price by Type (2019-2030) & (US$/kg)
 Figure 46. World Pediatric Orphan Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 47. World Pediatric Orphan Drug Production Value Market Share by Application in 2023
 Figure 48. 0-1 Years
 Figure 49. 1-3 Years
 Figure 50. 3-6 Years
 Figure 51. 6-12 Years
 Figure 52. ＞ 12 Years
 Figure 53. World Pediatric Orphan Drug Production Market Share by Application (2019-2030)
 Figure 54. World Pediatric Orphan Drug Production Value Market Share by Application (2019-2030)
 Figure 55. World Pediatric Orphan Drug Average Price by Application (2019-2030) & (US$/kg)
 Figure 56. Pediatric Orphan Drug Industry Chain
 Figure 57. Pediatric Orphan Drug Procurement Model
 Figure 58. Pediatric Orphan Drug Sales Model
 Figure 59. Pediatric Orphan Drug Sales Channels, Direct Sales, and Distribution
 Figure 60. Methodology
 Figure 61. Research Process and Data Source

Companies Mentioned

Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly